Seth Loring Harrison Net Worth - Insider Trades and Bio as of Jan 26, 2026

Seth Loring Harrison's Net Worth

$25.1 Million

Estimate Recalculated Dec 11, 2024 12:01AM EST

Who is Seth Loring Harrison

Seth Loring Harrison has an estimated net worth of $25.1 Million. This is based on reported shares across multiple companies, which include HeartWare LTD, Stoke Therapeutics, Inc., Akero Therapeutics, Inc., TITAN PHARMACEUTICALS INC, Tokai Pharmaceuticals Inc, and Cerecor Inc..

SEC CIK

Seth Loring Harrison's CIK is 0001404955

Past Insider Trading and Trends

2013 was Seth Loring Harrison's most active year for acquiring shares with 7 total transactions. Seth Loring Harrison's most active month to acquire stocks was the month of April. 2012 was Seth Loring Harrison's most active year for disposing of shares, totalling 13 transactions. Seth Loring Harrison's most active month to dispose stocks was the month of April. 2012 saw Seth Loring Harrison paying a total of $0.00 for 128,979 shares, this is the most they've acquired in one year. In 2016 Seth Loring Harrison cashed out on 143,143 shares for a total of $7,736,794.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

HeartWare International, Inc.

Investor

Updated Aug 24, 2016


Form 4	-100.00%	-160.08K	$58.00	-$8.81M	Aug 24, 2016	—	Disposition	—	Aug 23
Form 4	1.41%	2.00K	—	—	Jun 03, 2016	162.33K	Options	—	Jun 01
Form 4	—	—	—	—	May 02, 2016	152.08K	Options	—	May 01
Form 4	34.78%	2.00K	—	—	Jun 05, 2015	7.75K	Grant	—	Jun 03
Form 4	—	—	—	—	May 13, 2015	155.33K	Options	—	May 12
Form 4	—	—	—	—	May 04, 2015	155.33K	Options	—	May 01
Form 4	36.36%	2.00K	—	—	Jun 23, 2014	7.50K	Grant	—	Jun 04
Form 4	—	—	—	—	May 13, 2014	154.33K	Options	—	May 12
Form 4	—	—	—	—	May 02, 2014	154.33K	Options	—	May 01
Form 4	-48.15%	-3.25K	—	—	Feb 11, 2014	152.08K	Grant	—	Jan 28
Form 4	-5.64%	-7.91K	$99.29	-$785.28K	Jan 07, 2014	155.33K	Sale	Scheduled	Jan 06
Form 4	-8.55%	-13.12K	$95.57	-$1.25M	Jul 02, 2013	163.24K	Sale	—	Jul 01
Form 4	-54.48%	-210.43K	—	—	May 22, 2013	182.61K	Disposition	—	May 20 - May 21
Form 4	—	—	—	—	May 13, 2013	390.04K	Options	—	May 12
Form 4	—	—	—	—	May 06, 2013	390.04K	Options	—	May 04
Form 4	—	—	—	—	May 03, 2013	390.04K	Options	—	May 01
Form 4	-38.99%	-210.38K	—	—	Mar 20, 2013	387.96K	Disposition	—	Mar 18
Form 4	-15.62%	-1.25K	—	—	Mar 13, 2013	598.33K	Grant	—	Mar 11
Form 4	—	—	—	—	Jan 22, 2013	599.58K	Grant	—	Jan 16
Form 4	-28.05%	-210.38K	—	—	Jan 17, 2013	599.58K	Disposition	—	Jan 15
Form 4	-8.63%	-75.92K	$81.06	-$6.15M	Dec 18, 2012	809.96K	Sale	—	Dec 14
Form 4	-17.54%	-175.41K	$81.60	-$14.31M	Dec 13, 2012	885.88K	Sale	—	Dec 11 - Dec 13
Form 4	-6.86%	-73.63K	$81.22	-$5.98M	Dec 11, 2012	1.06M	Sale	—	Dec 07 - Dec 10
Form 4	-32.08%	-28.79K	$90.14	-$2.60M	Jul 16, 2012	1.13M	Sale	Scheduled	Jul 12 - Jul 16
Form 4	-1.35%	-1.23K	$90.00	-$110.25K	Jul 05, 2012	1.16M	Sale	Scheduled	Jul 02 - Jul 03
Form 4	64.87%	2.00K	—	—	Jun 04, 2012	5.08K	Grant	—	May 31
Form 4	—	—	—	—	May 14, 2012	1.17M	Options	—	May 12
Form 4	—	—	—	—	May 08, 2012	1.17M	Options	—	May 04
Form 4	-24.93%	-30.02K	$77.27	-$2.32M	Apr 30, 2012	1.16M	Sale	Scheduled	Apr 26
Form 4	-28.66%	-479.93K	—	—	Mar 05, 2012	1.19M	Disposition	—	Mar 01 - Mar 02
Form 4	120.05%	2.00K	—	—	May 16, 2011	3.67K	Grant	—	May 12
Form 4	—	—	—	—	May 06, 2011	1.67M	Options	—	May 04
Form 4	-37.40%	-1.00M	$77.86	-$77.85M	Dec 13, 2010	1.67M	Sale	—	Dec 09
Form 4	—	2.00K	—	—	May 06, 2010	2.00K	Grant	—	May 04
Form 4/A	0.05%	50.00K	$0.48	$24.18K	Sep 19, 2008	93.59M	Purchase	—	Sep 10 - Sep 11
Form 4	0.03%	50.00K	$0.49	$24.18K	Sep 11, 2008	187.12M	Purchase	—	Sep 10 - Sep 11
Form 4	0.02%	20.00K	$0.49	$9.80K	Sep 05, 2008	93.53M	Purchase	—	Sep 02
Form 4	0.01%	5.00K	$0.48	$2.40K	Sep 05, 2008	93.54M	Purchase	—	Sep 03
Form 4	0.03%	25.00K	$0.50	$12.50K	Sep 02, 2008	93.51M	Purchase	—	Sep 01
Form 4	0.73%	680.20K	$0.51	$346.90K	Aug 26, 2008	93.49M	Purchase	—	Aug 26
Form 4	0.04%	33.65K	$0.53	$17.83K	Aug 25, 2008	92.81M	Purchase	—	Aug 22
Form 4	0.20%	184.45K	$0.52	$95.92K	Aug 22, 2008	92.77M	Purchase	—	Aug 21
Form 4/A	0.18%	164.50K	$0.52	$85.54K	Aug 21, 2008	92.49M	Purchase	—	Aug 15
Form 4	0.11%	101.70K	$0.51	$51.87K	Aug 21, 2008	92.59M	Purchase	—	Aug 20
Form 4	0.18%	164.50K	$0.52	$85.54K	Aug 18, 2008	92.49M	Purchase	—	Aug 13
Form 4	0.80%	735.50K	$0.52	$382.46K	Aug 13, 2008	92.32M	Purchase	—	Aug 13
Form 3	—	—	—	—	Jun 28, 2007	91.59M	—	—	—

Showing 47 results

Stoke Therapeutics, Inc.

Investor

Updated Jun 07, 2024

View Quote Details


Form 4	—	7.64K	—	—	Jun 07, 2024	7.64K	Grant	—	Jun 05
Form 4	—	19.44K	—	—	Jun 15, 2023	19.44K	Grant	—	Jun 13
Form 4	—	21.00K	—	—	Jun 08, 2022	21.00K	Grant	—	Jun 07
Form 4	—	11.65K	—	—	Jun 25, 2021	11.65K	Grant	—	Jun 08
Form 4	2.23%	375.00K	$39.00	$14.63M	Nov 25, 2020	17.16M	Purchase	—	Nov 24
Form 4	—	14.78K	—	—	Jun 05, 2020	14.78K	Grant	—	Jun 03
Form 4	—	29.55K	—	—	Sep 12, 2019	29.56K	Grant	—	Sep 10
Form 4	9.02%	1.39M	$18.00	$25.00M	Jun 21, 2019	16.79M	Purchase	—	Jun 21
Form 3	—	—	—	—	Jun 18, 2019	—	—	—	—

Showing 9 results

Akero Therapeutics, Inc.

Investor

Updated Jun 11, 2024

View Quote Details


Form 4	—	26.00K	—	—	Jun 11, 2024	26.00K	Grant	—	Jun 08
Form 4	—	15.00K	—	—	Jun 27, 2023	15.00K	Grant	—	Jun 23
Form 4	-7.52%	-23.13K	$46.94	-$1.09M	Dec 02, 2022	284.36K	Sale	—	Nov 30
Form 4	-12.54%	-44.10K	$40.31	-$1.78M	Nov 01, 2022	307.50K	Sale	—	Oct 28
Form 4	-44.81%	-285.49K	$42.71	-$12.19M	Oct 27, 2022	351.60K	Sale	—	Oct 25 - Oct 27
Form 4	—	15.00K	—	—	Jun 03, 2022	15.00K	Grant	—	Jun 02
Form 4	—	13.00K	—	—	Jun 03, 2021	13.00K	Grant	—	Jun 01
Form 4	7.66%	415.00K	$36.00	$14.94M	Jul 14, 2020	5.83M	Purchase	—	Jul 10
Form 4	—	13.00K	—	—	Jun 02, 2020	13.00K	Grant	—	Jun 01
Form 4	—	26.00K	—	—	Nov 12, 2019	26.00K	Grant	—	Nov 08
Form 4	-60.99%	-8.47M	$16.00	—	Jun 25, 2019	5.42M	Buy-Options	—	Jun 24
Form 3	—	—	—	—	Jun 19, 2019	—	—	—	—
Form 3	—	—	—	—	Jun 19, 2019	—	—	—	—

Showing 13 results

TITAN PHARMACEUTICALS INC

Investor

Updated Dec 04, 2013

View Quote Details


Form 3	—	—	—	—	Dec 04, 2013	9.65M	—	—	—

Showing 1 results

Tokai Pharmaceuticals Inc

Investor

Updated Jun 16, 2016

View Quote Details


Form 4	—	12.00K	—	—	Jun 16, 2016	12.00K	Grant	—	Jun 15
Form 4	—	12.00K	—	—	Jun 19, 2015	12.00K	Grant	—	Jun 17
Form 4	-89.99%	-71.13M	$15.00	—	Sep 24, 2014	8.12M	Buy-Options	—	Sep 22
Form 3	—	—	—	—	Sep 16, 2014	212.70K	—	—	—

Showing 4 results

Cerecor Inc.

Investor

Updated Oct 20, 2015

View Quote Details


Form 4	-96.43%	-16.08M	—	—	Oct 20, 2015	595.44K	Options	—	Oct 20
Form 3	—	—	—	—	Oct 14, 2015	—	—	—	—

Showing 2 results